Kriya Therapeutics is a gene therapy company designing and developing transformative new treatments for a broad range of diseases.
Kriya Therapeutics is a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy. They have built a fully integrated engine that consolidates the critical infrastructure and technology needed to engineer, manufacture, characterize, and develop new gene therapies
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 16, 2022 | Series C | $270M | 1 | — | — | Detail |
| Jul 14, 2021 | Series B | $100M | 2 | — | — | Detail |
| May 12, 2020 | Series A | $80.50M | 1 | — | — | Detail |
| Oct 1, 2019 | Seed | — | 1 |
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series C |
|
|
— | Series B |